We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Nuclear Receptor Subfamily 0, Group B, Member 2 (NR0B2) Antibodies|
|Conjugate||This NR0B2 antibody is un-conjugated Alternatives|
Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
|Supplier||Log in to see|
Product Details anti-NR0B2 AntibodyTarget Details NR0B2 Application Details Handling Images
Rabbit Polyclonal antibody to NR0B2 (nuclear receptor subfamily 0, group B, member 2)
NR0B2 antibody [N2C3]
|Purification||Purified by antigen-affinity chromatography.|
|Immunogen||Recombinant protein encompassing a sequence within the center region of human NR0B2.|
|Plasmids, Primers & others|
Target Details NR0B2Product Details anti-NR0B2 Antibody Application Details Handling Images back to top
|Alternative Name||NR0B2 (NR0B2 Antibody Abstract)|
|Pathways||Nuclear Receptor Transcription Pathway, Positive Regulation of Peptide Hormone Secretion, Intracellular Steroid Hormone Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway|
Application DetailsProduct Details anti-NR0B2 Antibody Target Details NR0B2 Handling Images back to top
IHC-P: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10 mM Citrate buffer ( pH 6.0) or Tris-EDTA buffer ( pH 8.0)], ICC/IF: 1:100-1:1000.
Not yet tested in other applications.
Optimal working dilutions should be determined experimentally by the end user.
|Restrictions||For Research Use only|
HandlingProduct Details anti-NR0B2 Antibody Target Details NR0B2 Application Details Images back to top
0.1M Tris, 0.1M Glycine, 20 % Glycerol ( pH 7).
0.01 % Thimerosal was added as a preservative.
|Precaution of Use||This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
Keep as concentrated solution. Aliquot and store at -20°C or below.
Avoid multiple freeze-thaw cycles.
ImagesProduct Details anti-NR0B2 Antibody Target Details NR0B2 Application Details Handling back to top